Nautilus Biotechnology Inc reports results for the quarter ended in March - Earnings Summary

Nautilus Biotechnology

02/05/2023 14:32

* Nautilus Biotechnology Inc  NAUT.OQ  reported a quarterly
adjusted loss of 12 cents​​ per share for the quarter ended in
March. The mean expectation of three analysts for the quarter
was for a loss of 17 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Nautilus Biotechnology Inc's reported EPS for the quarter
was a
loss of 12 cents​.
    * The mean earnings estimate of analysts had risen by
about 9.1%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Nautilus Biotechnology Inc shares had fallen by 8.3% this
quarter and gained 41.1% so far this year.
    * The company reported a quarterly loss of $14.97 million.
    * Wall Street's median 12-month price target for Nautilus
Biotechnology Inc is $6.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
2 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.17          -0.12          Beat
 Dec. 31 2022      -0.15          -0.11          Beat
 Sep. 30 2022      -0.15          -0.11          Beat
 Jun. 30 2022      -0.17          -0.12          Beat